For Your Information: Antimicrobial Resistance

Questions

  1. What is Antimicrobial Resistance?
  2. What is the Issue?
  3. How does Antimicrobial Resistance develop?
  4. Are there any actions Canadians need to be taking now?
  5. What is Health Canada doing about Antimicrobial Resistance?
  6. How can I keep up-to-date on this issue?
  7. How can I get involved?

Answers

1. What is Antimicrobial Resistance?

The term antimicrobial refers to both natural and synthetic substances like antibiotics and disinfectants which can kill or inhibit the growth of microorganisms. Antimicrobial Resistance (AMR) occurs when an antimicrobial substance, or agent, is no longer effective in killing or inhibiting the growth of a particular microorganism.

Antimicrobial substances are widely used in human and veterinary medicine for the treatment and prevention of microbial infections and are also used for feed efficiency and to promote growth in animals in the agri-food industry.

The probability of an organism developing resistance increases with the length of time it is exposed to an antimicrobial agent. Bacterial strains are able to develop resistance to antimicrobial agents. Resistant bacterial strains survive and reproduce, transferring resistance to future generations and possibly to other microorganisms.

For example, a common bacterium, Salmonella, is often transmitted from animals to humans through the food chain. The emergence and dissemination of resistant Salmonella is of particular concern. Direct links have been made in some instances between veterinary antimicrobial use and the development of resistance in humans.

2. What is the Issue?

AMR is an important public health issue worldwide. The growth and proliferation of resistant bacteria may outpace our ability to control their effect on our health.

The increasing occurrence of AMR poses a threat to our ability to fight human and animal infections, and has potentially serious public health implications. Effective antibiotics could become fewer in number. This could make treatment more challenging and may increase health care costs.

AMR is a deeply debated subject, not only in Canada, but also internationally. There are varied opinions, perceptions and approaches involved in assessing and managing this issue. It is imperative that any decisions taken by the Government of Canada in this regard are based on the most accurate interpretation of available scientific evidence from a Canadian perspective.

3. How does Antimicrobial Resistance develop?

AMR can develop because of any one or combination of several of the following reasons:

1. Use in agri-food industries to treat specific diseases, or to prevent illness and promote growth.

2. Over-use and/or inappropriate use of antibiotics in human medicine:

3. Use of antibacterial cleaning products such as community or household disinfectants or antiseptics and personal hygiene products.

4. Environmental contamination caused by the use of cleaning and disinfectant products as well as veterinary antimicrobial drugs for use in farm and veterinary practice. The following are some examples of how this occurs:

4. Are there any actions Canadians need to be taking now?

Health Canada is continuing to assess potential risks and options to minimize risks and maximize benefits to Canadians and promote judicious use of antimicrobials. Here are some actions you can take:

If you handle livestock:

5. What is Health Canada doing about Antimicrobial Resistance?

Health Canada, while increasing educational and outreach activities on the AMR issue, is also spearheading a variety of activities including research, surveillance and policy development, as follows:

Within government:

With multi-stakeholder groups:

With partners:

Internationally:

In addition, several research projects are being undertaken to assess the association between antimicrobial use and resistance. The results of these assessments will enable the evaluation of resistance and the potential impact on human health. This will help us to gain more knowledge, as well as the ability to develop rapid diagnostic tests and new products for the specified length of time.

6. How can I keep up-to-date on this issue?

Research is underway and knowledge is increasing. As it becomes available, we will continue to post new information about AMR and our policies to address this issue on our Web site:

www.hc-sc.gc.ca/dhp-mps/vet/antimicrob/index-eng.php

7. How can I get involved?

Health Canada is working to make public participation part of policy development related to public health issues such as AMR. If you would like to comment or participate, please comment via our E-mail: vetdrugs-medsvet@hc-sc.gc.ca.

Health Canada contact information:

Veterinary Drugs Directorate
Health Products and Food Branch
Health Canada
Holland Cross Complex, Ground Floor
14 - 11 Holland Avenue
Ottawa, Ontario. K1A 0K9
Address Locator - 3000A

General Information Number : (613) 954-5687
Fax : (613) 957-3861

Glossary

Effluents: waste that is released in water from factories and processing plants

Extra-label drug use: when drugs are used for purposes other than which they were approved

Gut flora: microorganisms (including bacteria species) that are normally found in the intestinal tract of animals or humans

Microorganism: for purposes of this fact sheet, the definition includes: bacteria, yeast, protozoa, algae and virus

Pathogen: an agent that causes disease Broad-spectrum: drugs that treat a variety of micro-organisms

Page details

Date modified: